307 related articles for article (PubMed ID: 29399721)
1. Cannabinoid Receptors in Diabetic Kidney Disease.
Barutta F; Mastrocola R; Bellini S; Bruno G; Gruden G
Curr Diab Rep; 2018 Feb; 18(2):9. PubMed ID: 29399721
[TBL] [Abstract][Full Text] [Related]
2. The role of cannabinoid signaling in acute and chronic kidney diseases.
Barutta F; Bruno G; Mastrocola R; Bellini S; Gruden G
Kidney Int; 2018 Aug; 94(2):252-258. PubMed ID: 29706358
[TBL] [Abstract][Full Text] [Related]
3. Dual therapy targeting the endocannabinoid system prevents experimental diabetic nephropathy.
Barutta F; Grimaldi S; Gambino R; Vemuri K; Makriyannis A; Annaratone L; di Marzo V; Bruno G; Gruden G
Nephrol Dial Transplant; 2017 Oct; 32(10):1655-1665. PubMed ID: 28387811
[TBL] [Abstract][Full Text] [Related]
4. Cannabinoid Receptor 1 Inhibition in Chronic Kidney Disease: A New Therapeutic Toolbox.
Dao M; François H
Front Endocrinol (Lausanne); 2021; 12():720734. PubMed ID: 34305821
[TBL] [Abstract][Full Text] [Related]
5. Targeting the endocannabinoid system: future therapeutic strategies.
Aizpurua-Olaizola O; Elezgarai I; Rico-Barrio I; Zarandona I; Etxebarria N; Usobiaga A
Drug Discov Today; 2017 Jan; 22(1):105-110. PubMed ID: 27554802
[TBL] [Abstract][Full Text] [Related]
6. MECHANISMS IN ENDOCRINOLOGY: Endocannabinoids and metabolism: past, present and future.
Simon V; Cota D
Eur J Endocrinol; 2017 Jun; 176(6):R309-R324. PubMed ID: 28246151
[TBL] [Abstract][Full Text] [Related]
7. Plant-derived natural therapeutics targeting cannabinoid receptors in metabolic syndrome and its complications: A review.
Patil AS; Mahajan UB; Agrawal YO; Patil KR; Patil CR; Ojha S; Sharma C; Goyal SN
Biomed Pharmacother; 2020 Dec; 132():110889. PubMed ID: 33113429
[TBL] [Abstract][Full Text] [Related]
8. Cannabinoids in pain management: CB1, CB2 and non-classic receptor ligands.
Davis MP
Expert Opin Investig Drugs; 2014 Aug; 23(8):1123-40. PubMed ID: 24836296
[TBL] [Abstract][Full Text] [Related]
9. (+)-trans-Cannabidiol-2-hydroxy pentyl is a dual CB
González-Mariscal I; Carmona-Hidalgo B; Winkler M; Unciti-Broceta JD; Escamilla A; Gómez-Cañas M; Fernández-Ruiz J; Fiebich BL; Romero-Zerbo SY; Bermúdez-Silva FJ; Collado JA; Muñoz E
Pharmacol Res; 2021 Jul; 169():105492. PubMed ID: 34019978
[TBL] [Abstract][Full Text] [Related]
10. CB
Gallo Afflitto G; Aiello F; Scuteri D; Bagetta G; Nucci C
Biomed Pharmacother; 2022 Jun; 150():112981. PubMed ID: 35468582
[TBL] [Abstract][Full Text] [Related]
11. Endocannabinoids and the Digestive Tract and Bladder in Health and Disease.
Izzo AA; Muccioli GG; Ruggieri MR; Schicho R
Handb Exp Pharmacol; 2015; 231():423-47. PubMed ID: 26408170
[TBL] [Abstract][Full Text] [Related]
12. Overactive cannabinoid 1 receptor in podocytes drives type 2 diabetic nephropathy.
Jourdan T; Szanda G; Rosenberg AZ; Tam J; Earley BJ; Godlewski G; Cinar R; Liu Z; Liu J; Ju C; Pacher P; Kunos G
Proc Natl Acad Sci U S A; 2014 Dec; 111(50):E5420-8. PubMed ID: 25422468
[TBL] [Abstract][Full Text] [Related]
13. Potential of Cannabinoid Receptor Ligands as Treatment for Substance Use Disorders.
Galaj E; Xi ZX
CNS Drugs; 2019 Oct; 33(10):1001-1030. PubMed ID: 31549358
[TBL] [Abstract][Full Text] [Related]
14. Quetiapine induces myocardial necroptotic cell death through bidirectional regulation of cannabinoid receptors.
Li X; Peng Z; Zhou Y; Wang J; Lin X; Dong X; Liu X; Jiang J; Jiang Y; Li L
Toxicol Lett; 2019 Oct; 313():77-90. PubMed ID: 31220554
[TBL] [Abstract][Full Text] [Related]
15. Cannabinoid receptors in the kidney.
Hryciw DH; McAinch AJ
Curr Opin Nephrol Hypertens; 2016 Sep; 25(5):459-64. PubMed ID: 27367912
[TBL] [Abstract][Full Text] [Related]
16. Endocannabinoids and Mental Disorders.
Rubino T; Zamberletti E; Parolaro D
Handb Exp Pharmacol; 2015; 231():261-83. PubMed ID: 26408164
[TBL] [Abstract][Full Text] [Related]
17. Modulation of Renal GLUT2 by the Cannabinoid-1 Receptor: Implications for the Treatment of Diabetic Nephropathy.
Hinden L; Udi S; Drori A; Gammal A; Nemirovski A; Hadar R; Baraghithy S; Permyakova A; Geron M; Cohen M; Tsytkin-Kirschenzweig S; Riahi Y; Leibowitz G; Nahmias Y; Priel A; Tam J
J Am Soc Nephrol; 2018 Feb; 29(2):434-448. PubMed ID: 29030466
[TBL] [Abstract][Full Text] [Related]
18. The therapeutic potential of targeting the peripheral endocannabinoid/CB
Tam J; Hinden L; Drori A; Udi S; Azar S; Baraghithy S
Eur J Intern Med; 2018 Mar; 49():23-29. PubMed ID: 29336868
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular effects of marijuana and synthetic cannabinoids: the good, the bad, and the ugly.
Pacher P; Steffens S; Haskó G; Schindler TH; Kunos G
Nat Rev Cardiol; 2018 Mar; 15(3):151-166. PubMed ID: 28905873
[TBL] [Abstract][Full Text] [Related]
20. Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System.
Zou S; Kumar U
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29533978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
